Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in two segments, Biologics, and Pharma and Consumer Health. The Biologics segment provides formulation, development, and manufacturing for biologic proteins, cell gene, and other nucleic acid therapies; pDNA, iPSCs, oncolytic viruses, and vaccines; formulation, development, and manufacturing for parenteral dose forms, including vials, prefilled syringes, and cartridges; and analytical development and testing services for large molecules. The Pharma and Consumer Health segment offers formulation, development, and manufacturing services for soft capsules for use in a range of customer products, such as prescription drugs, over-the-counter medications, dietary supplements, unit-dose cosmetics, and animal health medicinal preparations; and oral, nasal, inhaled, and topical dose forms. This segment also provides clinical supply services through manufacturing, packaging, storage, distribution, and inventory management for small-molecule drugs, protein-based biologics, and cell and gene therapies in clinical trials; and pre-clinical screening, formulation, analytical development, and current good manufacturing practices manufacturing at clinical and commercial scale for softgel capsule, Zydis fast-dissolve tablets, oral solid-dose formats, dry powder inhalers, and nasal delivery devices. The company also offers FlexDirect direct-to-patient and FastChain demand-led clinical supply solutions; fill and finish operations for injectable products; and integrated development and product supply chain solutions. It serves biotechnology, pharmaceutical, and consumer health companies; and companies in other healthcare market segments, such as animal health and medical devices, as well as in cosmetics industries. The company was founded in 1933 and is headquartered in Somerset, New Jersey.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

iShares Core S&P 500 ETF

Fidelity Canadian Large Cap Sr B

American Funds American Balanced A

The Health Care Select Sector SPDR® ETF

The Merger Fund A

Vanguard Institutional Index I

Capital Group New Economy Comp

American Funds New Economy A

Fidelity Canadian Large Cp Mlt Ast Bs O

State St S&P 500® Indx SL Cl III

Vanguard Small Cap Index

Capital Group World Growth & Inc Cmp

American Funds Capital World Gr&Inc A

BlackRock Event Driven Equity Instl

Vanguard Small Cap Growth Index Inv

Invesco S&P 500® Equal Weight ETF

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

Vanguard Group Inc

BlackRock Inc

Fidelity International Ltd

Amvescap Plc.

Bank of America Corp

Eckert Corp

Amundi

Bank of Montreal

BMO Capital Markets Corp.

Charles Schwab Investment Management Inc

Northern Trust Corp

Deutsche Bank AG

State Street Corp

Capital World Investors

NORGES BANK

Millennium Management LLC

Barclays PLC

Geode Capital Management, LLC

Elliott Investment Management LP

Balyasny Asset Management LLC

Catalent Inc

Mr. John J. Greisch M.B.A.

Executive Chairman of the Board

Mr. Alessandro  Maselli

President, CEO & Director

Mr. Matti M. Masanovich

Senior VP & CFO

Ms. Lisa  Evoli

Senior VP & Chief Human Resources Officer

Mr. Ricky  Hopson

President, Division Head for BioProduct Delivery & Chief of Staff

Mr. David  McErlane

Group President of Biologics Segment

Mr. Michael J. Hatzfeld Jr.

VP & Chief Accounting Officer

Mr. Charles  Lickfold

Senior VP & Chief Information Officer

Mr. Paul  Surdez

Vice President of Investor Relations

Mr. Joseph A. Ferraro J.D.

Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary

Catalent Inc (CTLT) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Catalent Inc (CTLT) Earnings Report Date and History | NYSE

CTLT's next earnings is on February 7, 2025 (Before Market Open)

When is the earnings report for CTLT?

CTLT Earnings History

CTLT Stock Discussion Forum and Message Board

News for NYSE: CTLT